Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 14.4B | 16.1B | 17.1B | 16.5B |
Cost of revenue | — | — | — | — |
Gross profit | — | — | — | — |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 1.9B | 1.7B | 1.7B | 1.5B |
Operating income | — | — | — | — |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | — | — | — | — |
Other income expense | — | — | — | — |
Pretax income | -2.4B | 3.8B | 7.7B | 7.5B |
Tax provision | -327.1M | 976M | 2.0B | 2.0B |
Net income | -2.0B | 2.8B | 5.7B | 5.6B |
Basic EPS | — | 3.3 | 6.8 | 6.6 |
Diluted EPS | — | 3.3 | 6.8 | 6.6 |
Basic average shares | — | 857.3M | 845.4M | 842.9M |
Diluted average shares | — | 857.3M | 845.4M | 842.9M |
EBITDA | — | — | — | — |
Net income from continuing op. | — | — | — | — |
Minority interests | 120M | 36M | -14.3M | -19M |
Preferred stock dividends | — | — | — | — |